Dr. Lal PathLabs (NSE:LALPATHLAB) Cyclically Adjusted Book per Share: ₹0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LALPATHLAB Dr. Lal PathLabs Ltd NSE:LALPATHLAB
93 GF Score
Price ₹1,949.90
GF Value ₹1,735.83
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Dr. Lal PathLabs Cyclically Adjusted Book per Share?

Dr. Lal PathLabs NSE:LALPATHLAB -0.21% 93 Cyclically Adjusted Book per Share is ₹0.00 as of Jun. 2026. GuruFocus rates NSE:LALPATHLAB with a GF Score™ of 93/100 and a GF Value™ of ₹1,735.83 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dr. Lal PathLabs's adjusted book value per share for the three months ended in Jun. 2026 was ₹0.000. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Dr. Lal PathLabs's average Cyclically Adjusted Book Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-12), Dr. Lal PathLabs's current stock price is ₹1949.90. Dr. Lal PathLabs's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ₹0.00. Dr. Lal PathLabs's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr. Lal PathLabs was 22.13. The lowest was 13.55. And the median was 17.14.


Dr. Lal PathLabs  (NSE:LALPATHLAB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr. Lal PathLabs was 22.13. The lowest was 13.55. And the median was 17.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dr. Lal PathLabs Cyclically Adjusted Book per Share Related Terms


Dr. Lal PathLabs Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Dr. Lal PathLabs's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs Cyclically Adjusted Book per Share Chart

Dr. Lal PathLabs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 69.64 84.01 98.09

Dr. Lal PathLabs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 91.72 0.00 98.09 0.00

NSE:LALPATHLAB vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Cyclically Adjusted PB Ratio falls into.


NSE:LALPATHLAB
93GF Score
Dr. Lal PathLabs Ltd NSE:LALPATHLAB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Lal PathLabs Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr. Lal PathLabs's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/166.1454*166.1454
=0.000

Current CPI (Jun. 2026) = 166.1454.

Dr. Lal PathLabs Quarterly Data

Book Value per Share CPI Adj_Book
201609 36.253 105.961 56.844
201612 0.000 105.196 0.000
201703 35.846 105.196 56.615
201706 0.000 107.109 0.000
201709 40.920 109.021 62.361
201712 0.000 109.404 0.000
201803 47.271 109.786 71.538
201806 0.000 111.317 0.000
201809 52.441 115.142 75.670
201812 0.000 115.142 0.000
201903 56.724 118.202 79.732
201906 0.000 120.880 0.000
201909 63.486 123.175 85.634
201912 0.000 126.235 0.000
202003 61.960 124.705 82.550
202006 0.000 127.000 0.000
202009 69.380 130.118 88.590
202012 0.000 130.889 0.000
202103 74.693 131.771 94.178
202106 0.000 134.084 0.000
202109 82.266 135.847 100.614
202112 0.000 138.161 0.000
202203 91.109 138.822 109.042
202206 0.000 142.347 0.000
202209 93.506 144.661 107.393
202212 0.000 145.763 0.000
202303 100.451 146.865 113.638
202306 0.000 150.280 0.000
202309 106.598 151.492 116.909
202312 0.000 152.924 0.000
202403 111.117 153.035 120.637
202406 0.000 155.789 0.000
202409 120.149 157.882 126.437
202412 0.000 158.323 0.000
202503 130.309 157.552 137.417
202506 0.000 159.755 0.000
202509 143.039 162.289 146.438
202512 0.000 163.281 0.000
202603 150.208 164.272 151.921
202606 0.000 166.145 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹0.00 mean?
Dr. Lal PathLabs (NSE:LALPATHLAB) has a Cyclically Adjusted Book per Share of ₹0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr. Lal PathLabs and its competitors.
Is Dr. Lal PathLabs' Cyclically Adjusted Book per Share too high?
Dr. Lal PathLabs' current Cyclically Adjusted Book per Share is ₹0.00. Overall, Dr. Lal PathLabs has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Lal PathLabs' Cyclically Adjusted Book per Share compare to TMO and DHR?
Dr. Lal PathLabs' Cyclically Adjusted Book per Share of ₹0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr. Lal PathLabs and its competitors. Dr. Lal PathLabs's current Cyclically Adjusted Book per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Lal PathLabs stock overvalued right now?
Based on GuruFocus' analysis, Dr. Lal PathLabs (NSE:LALPATHLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,735.83, compared to a current price of ₹1,949.90 — trading 12.3% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₹0.00. Dr. Lal PathLabs' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Dr. Lal PathLabs (NSE:LALPATHLAB), the current Cyclically Adjusted Book per Share is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued. The current stock price of ₹1,949.90 is trading 12.3% above its estimated GF Value™ of ₹1,735.83. GuruFocus considers Dr. Lal PathLabs to be Modestly Overvalued.

Key valuation signals for NSE:LALPATHLAB:

  • Cyclically Adjusted Book per Share: ₹0.00
  • GF Value™: ₹1,735.83 vs. price of ₹1,949.90 (12.3% above fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the NSE:LALPATHLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr. Lal PathLabs Business Description

Other Exchanges 539524:India
Address 12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
93GF Score

Get the complete analysis for NSE:LALPATHLAB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,949.90
Price
₹1,735.83
GF Value